Tag: the lancet

April 10, 2018

Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology

Epizyme (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, announced today its first-in-human data on the effects of EZH2 inhibition...
March 15, 2018

Medical Cannabis an Effective Treatment for Childhood Epilepsy

Solid evidence for the use of cannabinoids in epilepsy is cause for optimism about the future of medical cannabis.
February 21, 2018

TG Therapeutics Announces Publication of Clinical Data from the Phase 1 First-in-Human Trial of Umbralisib

TG Therapeutics (NASDAQ:TGTX) announced the publication of the results from the Phase 1 first-in-human study of umbralisib (TGR-1202), the Company’s...
February 6, 2018

GW Pharmaceuticals’s CBD Candidate to Be Reviewed in Europe

GW Pharmaceuticals announced the European Medicines Agency accepted its application for Epidiolex, a cannabidiol treatment of seizures.
May 18, 2017

ENDRA Life Sciences Extends Deal with GE Healthcare

ENDRA Life Sciences renewed its global collaboration agreement with GE Healthcare to develop ENDRA's clinical platform Thermo-Acoustic Enhanced UltraSound.
February 17, 2017

Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG)  (“TiGenix”) today announced new data...
February 13, 2017

Medtronic Expands Coronary Portfolio to Include New DxTerity(TM) Diagnostic Catheters and Suite of Tools for the Transradial Approach

Medtronic plc (NYSE: MDT) today announced that its market-leading coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line...